Fabry Disease Clinical Trial Pipeline Major pharmaceutical companies are working to advance the pipeline space and unlock the future growth ...

Protalix and Chiesi have requested a meeting with the FDA to discuss the regulatory path toward PRX-102’s approval in the U.S. The companies plan to file a similar regulatory application with ...

Gambling content 21+. The New York Post may receive an affiliate commission if you sign up through our links. Read our editorial standards for more information. The UFC returns to the Apex for ...

beating the Heat 102-86 on Friday night. Miami shot 2 for 21 (9.5%) in the fourth quarter and was outscored 31-9 after leading by six through three quarters. The Heat didn't have Andrew Wiggins ...

Chiesi UK & Ireland has published new research revealing significant gaps in the understanding and practice of inhaler use among UK asthma patients. The study published in the BMJ Open Respiratory ...

Chiesi GRD has an initial focus in developing therapies for lysosomal storage disorders (LSDs), including Fabry disease, as well as other rare diseases in haematology and opthalmology indications.

Sam Sanders is returning to public radio’s national airwaves with his new KCRW show on media and entertainment. PRX will distribute The Sam Sanders Show, which premiered in October on the station in ...